Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Asthma & Allergy Center of Chicago, SC
1720
mi
from 91732
River Forest, IL
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Asthma & Allergy Center of Chicago, SC
1720
mi
from 91732
River Forest, IL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Clinical Research Facility
2615
mi
from 91732
South Portland, ME
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Clinical Research Facility
2615
mi
from 91732
South Portland, ME
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
VA WNY Healthcare System
2184
mi
from 91732
Buffalo, NY
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
VA WNY Healthcare System
2184
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Clinical Research Facility
2002
mi
from 91732
Asheville, NC
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Clinical Research Facility
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Clinical Research Facility
2040
mi
from 91732
Akron, OH
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
COR Clinical Research
1165
mi
from 91732
Oklahoma City, OK
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
COR Clinical Research
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Upstate Pharmaceutical Res.
2018
mi
from 91732
Greenville, SC
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Upstate Pharmaceutical Res.
2018
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Clinical Research Facility
2008
mi
from 91732
Anderson, SC
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Clinical Research Facility
2008
mi
from 91732
Anderson, SC
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Clinical Research Facility
1357
mi
from 91732
Houston, TX
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Manassas Clinical Research Center
2258
mi
from 91732
Manassas, VA
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Manassas Clinical Research Center
2258
mi
from 91732
Manassas, VA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  5/1/2012
Clinical Research Facility
2273
mi
from 91732
Annandale, VA
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 5/1/2012
Clinical Research Facility
2273
mi
from 91732
Annandale, VA
Click here to add this to my saved trials
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study
Status: Enrolling
Updated:  5/3/2012
New York State Psychiatric Institute
2435
mi
from 91732
New York, NY
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study
Status: Enrolling
Updated: 5/3/2012
New York State Psychiatric Institute
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics
Status: Enrolling
Updated:  5/4/2012
Kansas City VA Medical Center
1343
mi
from 91732
Kansas City, MO
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics
Tacrine Effects on Cocaine Self-Administration and Pharmacokinetics
Status: Enrolling
Updated: 5/4/2012
Kansas City VA Medical Center
1343
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Central Arkansas Veterans Health System
1461
mi
from 91732
Little Rock, AR
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Central Arkansas Veterans Health System
1461
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
LA County/USC Medical Center
11
mi
from 91732
Los Angeles, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
LA County/USC Medical Center
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of Southern California Medical Center
11
mi
from 91732
Los Angeles, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of Southern California Medical Center
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of California at San Diego
103
mi
from 91732
San Diego, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of California at San Diego
103
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of California, San Francincisco
353
mi
from 91732
San Francisco, CA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of California, San Francincisco
353
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Denver Department of Public Health and Hospitals
816
mi
from 91732
Denver, CO
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Denver Department of Public Health and Hospitals
816
mi
from 91732
Denver, CO
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Washington DC Veterans Administration Medical Center
2281
mi
from 91732
Washington DC,
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Washington DC Veterans Administration Medical Center
2281
mi
from 91732
Washington DC,
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Emory University School of Medicine
1922
mi
from 91732
Atlanta, GA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Emory University School of Medicine
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Chicago VA Medical Center (Lakeside)
1730
mi
from 91732
Chicago, IL
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Chicago VA Medical Center (Lakeside)
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Northwestern University
1730
mi
from 91732
Chicago, IL
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Northwestern University
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Hines VA Medical Center
1719
mi
from 91732
Hines, IL
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Hines VA Medical Center
1719
mi
from 91732
Hines, IL
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Johns Hopkins University School of Medicine
2302
mi
from 91732
Baltimore, MD
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Johns Hopkins University School of Medicine
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Boston Med Center
2578
mi
from 91732
Boston, MA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Boston Med Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
New Jersey Medical School
2423
mi
from 91732
Newark, NJ
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
New Jersey Medical School
2423
mi
from 91732
Newark, NJ
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Columbia University/Presbyterian Medical Center
2435
mi
from 91732
New York, NY
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Columbia University/Presbyterian Medical Center
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Harlem Hospital, Columbia University
2436
mi
from 91732
New York, NY
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Harlem Hospital, Columbia University
2436
mi
from 91732
New York, NY
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Duke Univ Med Ctr
2203
mi
from 91732
Durham, NC
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Nashville VA Medical Center
1762
mi
from 91732
Nashville, TN
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Nashville VA Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Veterans Administration Tennessee Valley Health Care System
1763
mi
from 91732
Nashville, TN
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Veterans Administration Tennessee Valley Health Care System
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
University of North Texas Health Science Center
1192
mi
from 91732
Fort Worth, TX
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
University of North Texas Health Science Center
1192
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Houston Veterans Administration Medical Center
1357
mi
from 91732
Houston, TX
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Houston Veterans Administration Medical Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Audi L. Murphy VA Hospital
1181
mi
from 91732
San Antonio, TX
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Audi L. Murphy VA Hospital
1181
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated:  5/7/2012
Seattle King County Health Department
961
mi
from 91732
Seattle, WA
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
Status: Enrolling
Updated: 5/7/2012
Seattle King County Health Department
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Exercise as a Behavioral Treatment for Cocaine Dependence
Exercise as a Behavioral Treatment for Cocaine Dependence
Status: Enrolling
Updated:  5/16/2012
Michael E. DeBakey Veterans Affairs Medical Center
1357
mi
from 91732
Houston, TX
Exercise as a Behavioral Treatment for Cocaine Dependence
Exercise as a Behavioral Treatment for Cocaine Dependence
Status: Enrolling
Updated: 5/16/2012
Michael E. DeBakey Veterans Affairs Medical Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Effect of Symbicort on Sleep Quality in Patients With Emphysema
Effect of Symbicort on Sleep Quality in Patients With Emphysema
Status: Enrolling
Updated:  5/18/2012
Temple Lung Center
2376
mi
from 91732
Philadelphia, PA
Effect of Symbicort on Sleep Quality in Patients With Emphysema
Effect of Symbicort on Sleep Quality in Patients With Emphysema
Status: Enrolling
Updated: 5/18/2012
Temple Lung Center
2376
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)
Nurse Managed Sequential Resistance Then Aerobic Training in COPD
Status: Enrolling
Updated:  5/29/2012
University of Illinois at Chicago
1729
mi
from 91732
Chicago, IL
Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD)
Nurse Managed Sequential Resistance Then Aerobic Training in COPD
Status: Enrolling
Updated: 5/29/2012
University of Illinois at Chicago
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Status: Enrolling
Updated:  6/1/2012
Wayne State University
1965
mi
from 91732
Detroit, MI
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Status: Enrolling
Updated: 6/1/2012
Wayne State University
1965
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
FAST as a Treatment for Obstructive Sleep Apnea
Functional Advancement and Suspension of the Tongue (FAST) as a Treatment for Obstructive Sleep Apnea
Status: Enrolling
Updated:  6/4/2012
The Atlanta Snoring and Sleep Disorders Institute
1919
mi
from 91732
Atlanta, GA
FAST as a Treatment for Obstructive Sleep Apnea
Functional Advancement and Suspension of the Tongue (FAST) as a Treatment for Obstructive Sleep Apnea
Status: Enrolling
Updated: 6/4/2012
The Atlanta Snoring and Sleep Disorders Institute
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
Sustained Impact of Hypertonic Saline on Mucociliary Clearance in Young Children With Cystic Fibrosis
Status: Enrolling
Updated:  6/6/2012
Univ of North Carolina
2194
mi
from 91732
Chapel Hill, NC
Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
Sustained Impact of Hypertonic Saline on Mucociliary Clearance in Young Children With Cystic Fibrosis
Status: Enrolling
Updated: 6/6/2012
Univ of North Carolina
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients
Assessment of The Clinical Course of Dyspnea and Its Association With Respiratory Rate in Patients With Acute Heart Failure Syndromes
Status: Enrolling
Updated:  6/7/2012
Northwestern Memorial Hospital
1730
mi
from 91732
Chicago, IL
Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients
Assessment of The Clinical Course of Dyspnea and Its Association With Respiratory Rate in Patients With Acute Heart Failure Syndromes
Status: Enrolling
Updated: 6/7/2012
Northwestern Memorial Hospital
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
Status: Enrolling
Updated:  6/8/2012
SUNY Upstate Medical University Hospital
2320
mi
from 91732
Syracuse, NY
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis
Status: Enrolling
Updated: 6/8/2012
SUNY Upstate Medical University Hospital
2320
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior
Modafinil Treatment for Cocaine Dependence and HIV-High Risk Behavior
Status: Enrolling
Updated:  6/13/2012
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior
Modafinil Treatment for Cocaine Dependence and HIV-High Risk Behavior
Status: Enrolling
Updated: 6/13/2012
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease
A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease.
Status: Enrolling
Updated:  6/18/2012
VA WNY Healthcare System
2184
mi
from 91732
Buffalo, NY
A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease
A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease.
Status: Enrolling
Updated: 6/18/2012
VA WNY Healthcare System
2184
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Improving Care of Patients With Heart Failure
A Randomized Controlled Trial for Patients With Heart Failure
Status: Enrolling
Updated:  6/26/2012
UCSF Medical Center
356
mi
from 91732
San Francisco, CA
Improving Care of Patients With Heart Failure
A Randomized Controlled Trial for Patients With Heart Failure
Status: Enrolling
Updated: 6/26/2012
UCSF Medical Center
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis
Stop Hypernatremia, Use Metolazone for Aggressive, Controlled, Effective Diuresis
Status: Enrolling
Updated:  6/26/2012
Oregon Health and Sciences University
829
mi
from 91732
Portland, OR
Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis
Stop Hypernatremia, Use Metolazone for Aggressive, Controlled, Effective Diuresis
Status: Enrolling
Updated: 6/26/2012
Oregon Health and Sciences University
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease
Status: Enrolling
Updated:  7/5/2012
University of North Carolina Hospitals
2189
mi
from 91732
Chapel Hill, NC
Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease
Status: Enrolling
Updated: 7/5/2012
University of North Carolina Hospitals
2189
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease
Status: Enrolling
Updated:  7/5/2012
University of North Carolina Hospitals - Sanford Specialty Clinics
2192
mi
from 91732
Sanford, NC
Use of FeNO to Identify Eosinophilic Inflammation in Patients Age 40 Years and Above With Chronic Obstructive Airways Disease
Status: Enrolling
Updated: 7/5/2012
University of North Carolina Hospitals - Sanford Specialty Clinics
2192
mi
from 91732
Sanford, NC
Click here to add this to my saved trials